Dermatology Times Newsletter

To view this email as a web page, click here.

You’re reading Legal Eagle, a column where David J. Goldberg, M.D., J.D., answers your legal questions. Do you have a topic you’d like Dr. Goldberg to discuss? Let us know.

Does FDA have jurisdiction over my comments?

Excited about a potentially less expensive, longer-lasting neuromodulator popular in South America, a physician discusses the product with the national press. A fellow dermatologist warns that this may lead to the FDA “coming after him,” but does FDA have jurisdiction over his comments in this case? Read this month’s Legal Eagle column to find out.

Can I import medications for poorer patients?

A physician tries to provide a better treatment option at a lower cost for his underinsured patients by importing medication from another country and finds himself in hot water with the FDA. Learn why.

I listened to my staff, how can I be sued?

A burn injury and questions unasked leads to a malpractice claim. Find out who is at fault in this article.

Connect with us on Twitter and Facebook for daily updates.

From our Latest Issue

Tips to minimize audit stress

Positive workplaces improve patient experiences

The psychosocial burden of acne

JOB OPPORTUNITIES

CA - Integrated Dermatology

CO-Integrated Dermatology

CT - Integrated Dermatology

District of Columbia-Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MS - Integrated Dermatology

National - Integrated Dermatology

NJ - Integrated Dermatology

NJ - Practice for Sale

NV - Integrated Dermatology

VA - Integrated Dermatology

VT - Integrated Dermatology

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.